IndraLab

Statements


MDM2 bound to CDKN2A inhibits TP53. 8 / 8
| 8

reach
"As mentioned above, ARF interaction with MDM2 causes MDM2 to target MDMX for degradation, and in the event of mitogenic stimulation MDMX is often downregulated to allow p53 activation."

reach
"In the case of MDM2-p53, it is apparent that both mechanisms are observed under different experimental conditions : induced phosphorylation of p53 can attenuate the p53-MDM2 interaction, and alternatively the human protein p14 ARF can bind to MDM2 and prevent its destruction of p53."

reach
"Indeed, it has been shown that ARF interacts with MDM2 and prevents MDM2 mediated degradation of p53 [XREF_BIBR]."

reach
"When released from nucleoli, Arf binds the central acidic region of MDM2 to inhibit its ubiquitinylation of p53."

reach
"The tumour suppressor P19 ARF associates with MDM2 to inhibit the ubiquitination, export and subsequent degradation of p53 [XREF_BIBR, XREF_BIBR]."

reach
"In vitro, nuclear p14 ARF binds Hdm2 to block Hdm2 dependent nucleocytoplasmic shuttling of p53, which is required before cytoplasmic degradation of p53."

reach
"ARF bound Hdm2 blocks Hdm2 dependent nucleocytoplasmic shuttling of p53, to produce nuclear retention and activation of p53 [XREF_BIBR, XREF_BIBR]."

reach
"ARF does this by binding to MDM2, a ubiquitin ligase that catalyses p53 degradation; this interaction sequesters MDM2 and also blocks its ligase activity, thereby stabilizing p53."